BST-CarGel Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
BST-CarGel General Information
Description
Developer of a first-line cartilage repair product. The company's product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears, enabling patients to get a faster recovery.
Contact Information
Corporate Office
- 475 boulevard Armand-Frappier
- Laval, Quebec H7V 4B3
- Canada
Corporate Office
- 475 boulevard Armand-Frappier
- Laval, Quebec H7V 4B3
- Canada
BST-CarGel Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
BST-CarGel Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
BST-CarGel FAQs
-
Where is BST-CarGel headquartered?
BST-CarGel is headquartered in Laval, Canada.
-
What industry is BST-CarGel in?
BST-CarGel’s primary industry is Therapeutic Devices.
-
Is BST-CarGel a private or public company?
BST-CarGel is a Private company.
-
What is the current valuation of BST-CarGel?
The current valuation of BST-CarGel is
. -
What is BST-CarGel’s current revenue?
The current revenue for BST-CarGel is
. -
Who are BST-CarGel’s investors?
Piramal Healthcare (Canada) has invested in BST-CarGel.
-
When was BST-CarGel acquired?
BST-CarGel was acquired on 08-Jan-2016.
-
Who acquired BST-CarGel?
BST-CarGel was acquired by Smith & Nephew.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »